Copeptin in Aortic Valve Replacement

Completed

• Conditions: Copeptin in Patients Undergoing Aortic Valve Replacement

• Registration Number: NCT01648647
• Lead Sponsor: Deutsches Herzzentrum Muenchen

Brief Summary

Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Detailed Description

Not available

Study Timeline

• Study Start: 2012-05
• Status Verified: 2012-07
• Study First Submitted: 2012-07-20
• Study First Submitted QC: 2012-07-20
• Last Update Submitted: 2012-07-20
• Study First Posted: 2012-07-24
• Last Update Posted: 2012-07-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Patients undergoing surgical aortic valve replacment
• Patients undergoing transcatheter aortic valve replacment

Exclusion Criteria

• denial by patient

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München; 🇩🇪 Munich, Bavaria, Germany